EHL BIO Expands Medical Network with the Establishment of Incheon Cell Center

Expanding Medical Partnerships in South Korea

EHL BIO is committed to enhancing access to innovative regenerative medicine throughout South Korea. On December 30, 2021, the company reached a significant milestone by signing a Memorandum of Understanding (MOU) with Joo Son Cheok Cheok Clinic to establish and support the Incheon Cell Center. This partnership represents a key step in expanding the foundation of cell therapy services to patients and health-conscious individuals across different regions.

The operations at the Incheon Cell Center will receive technical and management support from EHL BIO to ensure that services are delivered efficiently and meet the highest quality standards. This is in line with EHL BIO Research Institute's mission to overcome degenerative diseases and extend a high-quality lifespan for all.

Role of the Cell Center and Service Standards

The Incheon Cell Center serves as a vital hub for consultation and coordination in regenerative medicine. EHL BIO acts as the primary supporter, providing advanced cell culture technology under GMP (Good Manufacturing Practices) standards certified by the Korean Ministry of Food and Drug Safety (MFDS). Every process, from cell separation and storage to cultivation, is strictly controlled in Class 100 laboratories to maintain optimal cell viability.

Furthermore, this official partnership enables clients in the Incheon area to more conveniently access the latest innovations, such as Adipose-derived Stem Cells and Immune Cells. They benefit from a systematic and transparent cell management system compliant with South Korea's Advanced Regenerative Medicine and Biopharmaceuticals Act.

The establishment of the Incheon Cell Center represents our commitment to expanding the medical network to deliver cell regenerative technology to more people.

Innovations for Quality of Life by EHL BIO

The collaboration with local partners like the Incheon branch reflects the vision of EHL BIO CEO MD Hong-gi Lee, which focuses on utilizing medical and pharmaceutical technologies for the benefit of humanity. Stem cells, with their Homing Effect and Self-Renewal properties, have high potential for restoring tissues damaged by various conditions, including osteoarthritis, neurological issues, or Aging Well health management.

Expanding branches and a partner network of over 100 locations in South Korea and more than 50 worldwide—alongside collaborations with top medical institutions like Chungnam National University Hospital and Gangnam Severance Hospital—reinforces the confidence that clients at the Incheon Cell Center will receive modern health care strategies within EHL BIO's most advanced medical developments.

Service Procedures via EHL Thailand

For interested individuals from Thailand, EHL Thailand provides a comprehensive Thai-speaking coordination team. The process begins with an initial consultation via the website, followed by a health record evaluation by expert physicians. Afterward, a travel plan to South Korea is arranged for physical examinations and cell collection at the EHL Cell Clinic, which utilizes international standard cultivation and quality control systems.

Once the cultivation process in the GMP facility is complete, the client receives services according to the established plan. Continuous follow-up is provided after returning to Thailand to ensure that the recovery meets expectations and achieves a better quality of life according to EHL BIO's global standards.